The Advisory Board Company and UPMC Health Plan back $100m series B funding for their value-based care delivery company Evolent.

Imperial College London spin-out Circassia completes Phase II trials into grass allergy treatment.

Daiichi Sankyo has committed Y100m ($1m) and Mitsubishi UFJ Capital will be investing as much as Y200m ($2m) with the Organization for Small & Medium Enterprises and Regional Innovation pledging Y450m ($4.5m).

Four University of North Carolina spin-outs win $80k in commercialisation funds to help bring their technologies to market by Carolina Kickstart.

Body mapping startup BioDigital receives $4m from FirstMark Capital and New York University.